Chronic Pelvic Pain

Full Text Guidelines Summary of Changes Scientific Publications & Appendices Pocket Guidelines Archive Panel

2021

For the 2021 Chronic Pelvic Pain Guidelines, a new section has been included on Post-Surgical Pain Syndrome. In addition, the classifications in the Guideline have been amended to conform with revisions in the new International Classification of Diseases (ICD-11) released by the World Health Organization. The latest version of ICD-11 will be available for member states to report with as from January 2022.

Slight amendments to the wording of some recommendations have been made.

2020

For the 2020 Chronic Pelvic Pain Guidelines, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Chronic Pelvic Pain Guidelines was performed. Embase, Medline, the Cochrane Central Register of Controlled Trials and CINAHL databases were searched and papers were restricted to English language publications. Additional references and text updates have been incorporated throughout the text as a result of this search. In addition, a review of all the references has been undertaken by the Panel and those considered of a low-level of evidence have been removed.

2019

For the 2019 Chronic Pelvic Pain Guidelines, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Chronic Pelvic Pain Guidelines was performed. Embase, Medline, the Cochrane Central Register of Controlled Trials and CINAHL databases were searched and papers were restricted to English language publications. Additional references and text updates have been incorporated throughout the text as a result of this search.

A new section and recommendation has been included on surgical mesh.

2018

For the 2018 edition of the EAU Chronic Pelvic Pain Guidelines, the Guidelines Office have transitioned to a modified GRADE methodology. For each recommendation within the guidelines there is an accompanying online strength rating form which addresses a number of key elements namely:

  1. the overall quality of the evidence which exists for the recommendation;
  2. the magnitude of the effect (individual or combined effects);
  3. the certainty of the results (precision, consistency, heterogeneity and other statistical or study related factors);
  4. the balance between desirable and undesirable outcomes;
  5. the impact of patient values and preferences on the intervention;
  6. the certainty of those patient values and preferences.

These key elements are the basis which panels use to define the strength rating of each recommendation. The strength of each recommendation is determined by the balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence, and nature and variability of patient values and preferences. The strength of each recommendation is represented by the words ‘strong’ or ‘weak’.

In addition, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Chronic Pelvic Pain Guidelines was performed. Additional references and text updates have been incorporated throughout the text as a result of this search.

2017

For the 2017 Chronic Pelvic Pain Guidelines, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Chronic Pelvic Pain Guidelines was performed. Embase, Medline, the Cochrane Central Register of Controlled Trials and CINAHL databases were searched and papers were restricted to English language publications. Additional references and text updates have been incorporated throughout the text as a result of this search.

2016

No significant new information has been included for the 2016 print.  However, the text has been re-formatted according to the EAU non-oncology template so that all Guidelines follow a similar format.

2015

For the 2015 Guidelines, the text has been significantly reduced so that only key information is included.

2014

Chapter 3.1 PPS (changed to 3.2)
– Introduction added

Chapter 3.2 BPS Diagnosis section (changed to 3.3)
– Condensed, references cut from 147 to 137.
– No further changes

Chapter 3.2 BPS Treatment section
– Condensed and section added on Tanezumab

Chapter 4 Gynaecology
– No changes

Chapter 5 Gastroenterology
– Section on Anal fissure further expanded
– Section and recommendations added on SNS & PTNS. Algorithms adjusted accordingly.
– Section on IBS was first added, but then removed still no consensus as to whether the CPP should cover this topic

Chapter 6 Peripheral nerve
– Minor ref update, no further changes

Chapter 7 Sexology
– No changes

Chapter 8 Psychology
– Slight revisions throughout + ref update

Chapter 9 Pelvic floor
– Minor ref update

Chapter 10 General treatment
– No changes

2012

– Complete update

2020

For the 2020 Chronic Pelvic Pain Guidelines, new and relevant evidence has been identified, collated and appraised through a structured assessment of the literature. A broad and comprehensive literature search, covering all sections of the Chronic Pelvic Pain Guidelines was performed. Embase, Medline, the Cochrane Central Register of Controlled Trials and CINAHL databases were searched and papers were restricted to English language publications. Additional references and text updates have been incorporated throughout the text as a result of this search. In addition, a review of all the references has been undertaken by the Panel and those considered of a low-level of evidence have been removed.